CDC Advisory Committee Recommends MPOX Vaccine for High-Risk Men

United States of America
The CDC's Advisory Committee on Immunization Practices recommended the MPOX vaccine for high-risk men.
The MPOX vaccine was developed by Bavarian Nordic.
The recommendation was based on the vaccine's efficacy and safety data.

On October 26, 2023, the U.S. Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) recommended the use of the MPOX vaccine for high-risk men. The MPOX vaccine, developed by Bavarian Nordic, is designed to prevent the spread of the MPOX virus, a highly contagious disease. The ACIP's recommendation was based on the vaccine's efficacy and safety data. The committee's decision was not unanimous, with some members expressing concerns about the vaccine's potential side effects. However, the majority of the committee members agreed that the benefits of the vaccine outweigh the potential risks for high-risk men. The CDC will consider the ACIP's recommendation in its final decision on the use of the MPOX vaccine.


Confidence

95%

Doubts
  • There is a lack of information on the specific side effects of the MPOX vaccine.

Sources

92%

  • Unique Points
    • The article provides detailed information about the MPOX vaccine, including its effectiveness and potential side effects.
    • The article includes quotes from CDC advisers and other health experts.
  • Accuracy
    No Contradictions at Time Of Publication
  • Deception (100%)
    None Found At Time Of Publication
  • Fallacies (100%)
    None Found At Time Of Publication
  • Bias (90%)
    • The article seems to favor the CDC's recommendation, without presenting any opposing views or potential drawbacks of the vaccine.
    • Site Conflicts Of Interest (85%)
      • CNN is owned by WarnerMedia News & Sports, a division of AT&T's WarnerMedia. AT&T has been known to donate to both Democratic and Republican parties, which could potentially influence the site's reporting.
      • Author Conflicts Of Interest (100%)
        None Found At Time Of Publication

      90%

      • Unique Points
        • The article provides information about Bavarian Nordic, the company that produces the MPOX vaccine.
        • The article includes data on the number of men who could potentially benefit from the vaccine.
      • Accuracy
        No Contradictions at Time Of Publication
      • Deception (100%)
        None Found At Time Of Publication
      • Fallacies (100%)
        None Found At Time Of Publication
      • Bias (85%)
        • The article seems to favor the CDC's recommendation and the Bavarian Nordic's MPOX vaccine, without presenting any opposing views or potential drawbacks of the vaccine.
        • Site Conflicts Of Interest (85%)
          • AOL is owned by Verizon Communications. Verizon has been known to lobby for telecommunications regulations and has made significant political contributions to both Democratic and Republican parties, which could potentially influence the site's reporting.
          • Author Conflicts Of Interest (100%)
            None Found At Time Of Publication

          93%

          • Unique Points
            • The article provides information about the ongoing debate regarding the MPOX vaccine.
            • The article includes quotes from CDC advisers and other health experts.
          • Accuracy
            No Contradictions at Time Of Publication
          • Deception (100%)
            None Found At Time Of Publication
          • Fallacies (100%)
            None Found At Time Of Publication
          • Bias (90%)
            • The article seems to favor the CDC's recommendation, without presenting any opposing views or potential drawbacks of the vaccine.
            • Site Conflicts Of Interest (90%)
              • US News is owned by U.S. News & World Report, L.P., a privately held company. The company's ownership and potential political affiliations are not publicly disclosed, which could potentially influence the site's reporting.
              • Author Conflicts Of Interest (100%)
                None Found At Time Of Publication